Clinical Trials Directory

Trials / Unknown

UnknownNCT00821275

Clinical Trial of Uterine Artery Embolization for Uterine Leiomyoma

Multi-Center Clinical Trial of Uterine Artery Embolization Treatment of Uterine Leiomyoma

Status
Unknown
Phase
Phase 2 / Phase 3
Study type
Interventional
Enrollment
900 (estimated)
Sponsor
Sun Yat-sen University · Academic / Other
Sex
Female
Age
20 Years – 50 Years
Healthy volunteers
Not accepted

Summary

The efficacy and safety of uterine artery embolization, as compared with standard surgical methods, for the treatment of symptomatic uterine fibroids remain uncertain. The purpose of this trial is to evaluate the uterine volume and tumor size reduction, symptomatic relief, complication, fertility, ovarian function and quality of life with uterine artery embolization for uterine fibroids comparing with standard surgical methods.

Conditions

Interventions

TypeNameDescription
PROCEDUREInterventional radiological or surgical managementUterine artery embolization will be done for the patients who enroll into UAE group and desire for future pregancy and reserving uterus.Myomectomy will be performed for the patients who enroll into SURGERY group and desire for future pregancy and reserving uterus.Hysterectomy will be done for the patients who enroll into SURGERY group and don't desire for reserving uterus and/or future pregnancy.

Timeline

Start date
2008-01-01
Primary completion
2018-12-01
Completion
2018-12-01
First posted
2009-01-13
Last updated
2009-01-13

Locations

4 sites across 1 country: China

Source: ClinicalTrials.gov record NCT00821275. Inclusion in this directory is not an endorsement.

Clinical Trial of Uterine Artery Embolization for Uterine Leiomyoma (NCT00821275) · Clinical Trials Directory